Skip to content

Changes in the immunomodulatory properties of Adipose Stromal cells due to Hemarthrosis after knee injury

Changes in the immunomodulatory properties of Adipose Stromal cells due to Hemarthrosis after knee injury - CASH

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50890
Enrollment
20
Registered
2021-06-10
Start date
2022-05-31
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-traumatic arthrosis post-traumatic osteoarthritis joint degeneration after injury

Interventions

questioniare&nbsp
physical exam of the kneeintra-articulair joint puncture for synovial fluid aspiration

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 10 patients with hemarthrosis 10 patients without hemarthrosis -18 years or older -Recently suffered an injury of the index knee (rotational or hyperextension) -A swollen kneejoint -Inability to mobilise

Exclusion criteria

Exclusion criteria: - Patients with an active inflammatory or infectious comorbid disease (including rheumatic diseases) - Patients with knee prosthesis - Patients with coagulation disorders - Patients with a history of a cruciate ligament or meniscal injury of the index knee - Patients with a tibiofemoral fracture due to current distorsion

Design outcomes

Primary

MeasureTime frame
The anti-inflammatory capacities of ASC*s in synovial fluid that contains blood as a result of hemarthrosis after knee injury compared to the anti-inflammatory capacities of ASC's in synovial fluid that does not contain blood.

Secondary

MeasureTime frame
- The natural course of pro-inflammatory factors levels and hemarthrosis related factor levels in the first weeks after trauma - The correlation between pro-inflammatory factors and hemarthrosis - The correlation between levels of pro-inflammatory factor levels and hemarthrosis related factor levels with the clinical presentation on the endpoints: swelling, pain and function impairment

Countries

Netherlands

Contacts

Public ContactB.J. Evers

Radboud Universitair Medisch Centrum

bob.j.evers@radboudumc.nl06-54287103

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026